Edwards Lifesciences (EW) Gains from Sales and Divestitures (2013 - 2014)
Edwards Lifesciences (EW) recorded quarterly Gains from Sales and Divestitures of $200000.0 in Q4 2014, down 33.33% quarter-over-quarter from $300000.0 in Q4 2013, and down 33.33% on a YoY basis from $300000.0 in Q4 2013.
Edwards Lifesciences (EW) Gains from Sales and Divestitures (2013 - 2014) Analysis & Trends
Edwards Lifesciences' Gains from Sales and Divestitures history runs 2 years deep, the most recent figure standing at $200000.0 for Q4 2014.
- In Q4 2014, Gains from Sales and Divestitures fell 33.33% year-over-year to $200000.0; the TTM figure through Dec 2014 stood at $200000.0 (down 33.33% YoY), while the FY2014 annual figure was $200000.0, down 33.33% from the prior year.
- Gains from Sales and Divestitures was $200000.0 for Q4 2014 at Edwards Lifesciences, down from $300000.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $300000.0 in Q4 2013 to a low of $200000.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 200,000.00 |
| Dec 31, 2014 | 200,000.00 |
| Dec 31, 2013 | 300,000.00 |
| Dec 31, 2013 | 300,000.00 |